Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Are Asian ETFs in Jeopardy Amid the War & Tariff Double Whammy?: https://staticx-tuner.zacks.com/images/articles/main/6b/149756.webp
Are Asian ETFs in Jeopardy Amid the War & Tariff Double Whammy?

The Asia region is currently grappling with a severe economic double-whammy — a sharp oil price shock and tightening supply-chain bottlenecks. As the 2026 Middle East conflict escalates, Brent crude

2 Dividend Stocks Insulated From Middle East Conflict
2 Dividend Stocks Insulated From Middle East Conflict

The war in Iran has already sent multiple shockwaves through the markets. Gas prices have soared, tankers are on fire in the Strait of Hormuz, and crude oil futures are trading like 2021 meme

UiPath and Unified Automation: What's Driving ARR Growth
UiPath and Unified Automation: What's Driving ARR Growth

Enterprise automation budgets are shifting from point tools to platforms. Buyers want governance, reuse, and faster time to value across UI, API and document-heavy work. UiPath PATH is leaning into

Bargain Alert: Wells Fargo and Goldman Sachs Look Deeply Oversold
Bargain Alert: Wells Fargo and Goldman Sachs Look Deeply Oversold

Financial stocks have faced a difficult stretch in recent weeks. Rising geopolitical tensions have rattled global markets and pushed investors toward safer assets, while concerns about the

MKSI Gets SBTi Approval for 2030 Science-Based Emission Targets
MKSI Gets SBTi Approval for 2030 Science-Based Emission Targets

MKS MKSI shares have surged 148.1% in the past year, outperforming the Zacks Computer & Technology sector’s growth of 31.9%. The surge can be attributed mainly to strong revenue and profit growth

AWR Gains From Investment & Rising Demand as Customer Base Expands
AWR Gains From Investment & Rising Demand as Customer Base Expands

American States Water AWR continues to benefit from a regulated structure, strong demand from an expanding customer base, strategic capital investment and a diversified business model that provides

Nu Holdings Turns Expanding Customer Base Into Profitable Growth
Nu Holdings Turns Expanding Customer Base Into Profitable Growth

Nu Holdings’ NU accelerating customer count is the foundation of its continued success in Latin America. In the fourth quarter of 2025, the company reached 131 million customers across its

Quantum Computing Set to Scale in 2026: IONQ, QBTS, RGTI's Outlook
Quantum Computing Set to Scale in 2026: IONQ, QBTS, RGTI's Outlook

Amid macroeconomic uncertainty and volatile technology spending in 2026, the quantum computing industry is gradually transitioning from research-led experimentation toward early commercialization

Berkshire vs. Allstate: Which Insurance Leader Is the Better Pick?
Berkshire vs. Allstate: Which Insurance Leader Is the Better Pick?

Improved pricing, rising climate-related risks and rapid digitization are poised to shape the insurance industry's trajectory in 2026. While insurers continue to face exposure to catastrophe losses

Here's How the Test Systems Segment Powers Astronics' Growth Story
Here's How the Test Systems Segment Powers Astronics' Growth Story

Astronics Corporation’s ATRO Test Systems segment is gradually emerging as an important contributor to the company’s long-term growth, positioning it to benefit from structural expansion in

PATH Delivers Strong Quarter to Close its Fiscal Year: Is PATH a Buy?
PATH Delivers Strong Quarter to Close its Fiscal Year: Is PATH a Buy?

UiPath PATH ended its fiscal year on a strong note, reporting results that exceeded the upper end of its guidance across major financial metrics. The quarter reflected continued demand for

IBRX and the BCG Shortage: A 2026 Catalyst Investors Are Tracking
IBRX and the BCG Shortage: A 2026 Catalyst Investors Are Tracking

ImmunityBio IBRX is scaling a strategy that sits at the intersection of a persistent Bacillus Calmette-Guérin (BCG) shortage and expanding use of its lead immunotherapy, Anktiva. That combination is

3 Strong Buy Stocks Under $10
3 Strong Buy Stocks Under $10
  • (1:00) - Where Can You Find Strong Investments For A Deal?
  • (5:45) - Tracey’s Top Stock Picks For Your Watchlist Right Now
  • (23:00) - Episode Roundup: CLDT, INNV, BCBP
  •                 Podcast@Zacks.
ImmunityBio Valuation: Paying 33x Sales for Anktiva
ImmunityBio Valuation: Paying 33x Sales for Anktiva

ImmunityBio’s IBRX stock has re-rated sharply as Anktiva transitions from a newly launched therapy to a product with accelerating prescriptions, expanding geographies, and active label-extension

IBRX Stock: Anktiva's Approvals and What Comes Next
IBRX Stock: Anktiva's Approvals and What Comes Next

ImmunityBio IBRX has entered a new phase as a commercial-stage immunotherapy developer. The company’s near-term trajectory is closely tied to a single asset, Anktiva, which now anchors both revenue

Amkor Eyes Strong Second Half 2026 as AI, HPC Packaging Demand Surges
Amkor Eyes Strong Second Half 2026 as AI, HPC Packaging Demand Surges

Amkor Technology AMKR is lining up for a pivotal second half of 2026 as structural artificial intelligence (AI) and high-performance computing (HPC) demand accelerates advanced packaging activity

Franco-Nevada May Be the Best Way to Play a Commodity Supercycle
Franco-Nevada May Be the Best Way to Play a Commodity Supercycle

After an initial pop after earnings, Franco-Nevada Corp. (NYSE: FNV) stock is basically flat since it reported fourth-quarter earnings on March 10. The royalty/streaming company had a strong

Oracle: The AI Darkhorse?
Oracle: The AI Darkhorse?

Between spring and summer of last year, Oracle (ORCL) stock nearly tripled as maverick founder and CEO Larry Ellison laid everything on the line to join the AI race. The stock surged from under $130

CRH and the Data Center Buildout: What Investors Miss
CRH and the Data Center Buildout: What Investors Miss

CRH plc CRH is often framed as a beneficiary of U.S. roads and bridges spending, but a quieter demand driver is building alongside it. Digital infrastructure is emerging as a meaningful throughput

Lennar's Q1 Earnings & Revenues Miss, New Home Orders Up Y/Y
Lennar's Q1 Earnings & Revenues Miss, New Home Orders Up Y/Y

Lennar Corporation LEN reported tepid results for the first quarter of fiscal 2026, wherein its adjusted earnings and total revenues missed the Zacks Consensus Estimate and declined year over

Is CRH a Buy at 16X Earnings? Price Target and Key Risks
Is CRH a Buy at 16X Earnings? Price Target and Key Risks

CRH plc CRH sits at an interesting crossroads. The stock trades at a discount to broad benchmarks, yet its near-term earnings narrative is getting tougher as estimates drift lower. At the same time

MP Materials Trades at a Premium: Buy, Sell or Hold the Stock?
MP Materials Trades at a Premium: Buy, Sell or Hold the Stock?

MP Materials MP is trading at a forward 12-month price/sales multiple of 20.95X, a significant premium to the industry’s 1.43X. It has a Value Score of F, which suggests that the stock appears

FORM Surges 188% in 6 Months:Will the Momentum Continue in 2026?
FORM Surges 188% in 6 Months:Will the Momentum Continue in 2026?

FormFactor’s FORM shares have surged 187.8% in the trailing six months, outperforming the broader Zacks Computer and Technology sector’s growth of 0.3% and the Zacks Electronics- Semiconductors

OXY Outperforms Industry in Past Month: Buy, Hold or Sell the Stock?
OXY Outperforms Industry in Past Month: Buy, Hold or Sell the Stock?

Occidental Petroleum Corporation’s OXY shares have gained 26.8% in the past months compared with the Zacks Oil and Gas-Integrated-United States industry’s rise of 10%. The company has also

Can Hecla Mining Hold on to Its Strong Silver Production Momentum?
Can Hecla Mining Hold on to Its Strong Silver Production Momentum?

Hecla Mining Company HL delivered strong operational performance in 2025, with solid silver production emerging as a key contributor to its quarterly results and strengthening investor confidence